Antibodies better than chemo with stem cell transplant

09/3/2009 | Yahoo!

Treatment with monoclonal antibodies instead of high-dose chemotherapy might help children with primary immunodeficiencies get the most from stem cell transplants, British researchers reported. Monoclonal antibodies target only the immune cells that cause rejection and not other body tissue, allowing patients to recover more quickly and avoid the toxicity from chemotherapy, the study found.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC